# Piramal Pharma Limited – FDA Inspection, Aug 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/86b06f35-28c9-4f71-bae0-6fefd203f2c6
Source feed: FDA_Inspections

> FDA inspection 1103288 of Piramal Pharma Limited, August 30, 2019. Classification: No Action Indicated (NAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1103288
- Company Name: Piramal Pharma Limited
- Inspection Date: 2019-08-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1208559 - 2023-05-19
- FDA Inspection 1081925 - 2019-01-18
- [FDA Inspection 1005197 - 2017-02-21](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/4d5108d6-21cc-4fe9-b32e-d5c82096ac34)
- FDA Inspection 951067 - 2015-10-30
- [FDA Inspection 924411 - 2015-04-03](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/19284a5c-c477-4460-8928-1c97b042bde0)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/piramal-pharma-limited/b492136d-42a5-47e3-a443-53373398d2c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c